Galectin Therapeutics Statistics

Total Valuation

GALT has a market cap or net worth of $144.16 million. The enterprise value is $265.76 million.

Market Cap	144.16M
Enterprise Value	265.76M

Important Dates

The last earnings date was Friday, May 15, 2026, before market open.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

GALT has 65.83 million shares outstanding. The number of shares has increased by 3.09% in one year.

Current Share Class	65.83M
Shares Outstanding	65.83M
Shares Change (YoY)	+3.09%
Shares Change (QoQ)	+1.60%
Owned by Insiders (%)	19.83%
Owned by Institutions (%)	21.49%
Float	47.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.15

Current Ratio	2.15
Quick Ratio	1.93
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.15

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-80.40%
Return on Invested Capital (ROIC)	-1,239.71%
Return on Capital Employed (ROCE)	-192.44%
Weighted Average Cost of Capital (WACC)	5.61%
Revenue Per Employee	n/a
Profits Per Employee	-$2.93M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +71.09% in the last 52 weeks. The beta is 0.45, so GALT's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+71.09%
50-Day Moving Average	2.53
200-Day Moving Average	3.90
Relative Strength Index (RSI)	43.56
Average Volume (20 Days)	297,428

Short Selling Information

The latest short interest is 7.39 million, so 11.22% of the outstanding shares have been sold short.

Short Interest	7.39M
Short Previous Month	7.46M
Short % of Shares Out	11.22%
Short % of Float	15.67%
Short Ratio (days to cover)	21.93

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.27M
Pretax Income	-26.25M
Net Income	-26.38M
EBITDA	n/a
EBIT	-16.27M
Earnings Per Share (EPS)	-$0.41

Full Income Statement

Balance Sheet

The company has $14.11 million in cash and $135.71 million in debt, with a net cash position of -$121.60 million or -$1.85 per share.

Cash & Cash Equivalents	14.11M
Total Debt	135.71M
Net Cash	-121.60M
Net Cash Per Share	-$1.85
Equity (Book Value)	-130.24M
Book Value Per Share	-2.01
Working Capital	8.38M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-20.05M
Capital Expenditures	n/a
Depreciation & Amortization	55,000
Net Borrowing	21.00M
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GALT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.09%
Shareholder Yield	-3.09%
Earnings Yield	-18.30%
FCF Yield	n/a

Analyst Forecast

The average price target for GALT is $11.00, which is 402.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.00
Price Target Difference	402.28%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 23, 2012. It was a reverse split with a ratio of 1:6.

Last Split Date	Mar 23, 2012
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	2